Meeting
2019 ASCO Annual Meeting
Can pediatric and adolescent patients with recurrent tumors benefit from a precision medicine program? The European MAPPYACTS experience.
Authors
Pablo Berlanga
Gustave Roussy Cancer Campus, Villejuif, France
Pablo Berlanga , Gaëlle Pierron , Ludovic Lacroix , Tiphaine Adam de Beaumais , Virginie Bernard , Sophie Cotteret , Nicolas Andre , Nadege Corradini , Estelle Thebaud , Samuel Abbou , Michela Casanova , Cormac Owens , Stefan Michiels , Olivier Delattre , Gilles Vassal , Gudrun Schleiermacher , Birgit Geoerger
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Clinical Trial Registration Number
NCT02613962
Citation
J Clin Oncol 37, 2019 (suppl; abstr 10018)
DOI
10.1200/JCO.2019.37.15_suppl.10018
Abstract #
10018
Poster Bd #
400
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Therapeutic implications of phosphoproteomics in molecular cancer diagnostics.
First Author: Annika Schneider
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The Endoscopic Ultrasound Molecular Analysis of Pancreatic Cancer (EUMEPC) study.
First Author: Joanne Lundy
Poster
2022 ASCO Quality Care Symposium
Implementation of a virtual, on-demand, molecular tumor board at a large, multi-clinic, community oncology practice.
First Author: Andrew Jacob McKenzie
Poster
2022 ASCO Genitourinary Cancers Symposium
First results of the PROMPT trial: Precision oncology allocation in patients with early castration-resistant prostate cancer following routine molecular profiling.
First Author: Iris S. H. Kloots